Condition: Descending Aortic Dissection · Postoperative Pain · Thoracoabdominal Aortic Aneurysm · Sponsor: Sam Tyagi
The objective of this study is to identify the opioid-sparing effects, and pain-reduction potential of low dose, sub-dissociative ketamine on patients undergoing thoracic endovascular aortic repair (TEVAR) procedures receiving naloxone continuous infusion (NCI).
This description comes directly from the study's public registry record.
Eric Johnson, PharmD · 8593235722 · eric.johnson@uky.edu
Always discuss trial participation with your own doctor first.
| University of Kentucky Medical Center | Lexington, Kentucky, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04600089